Roche / Genentech
F. Hoffmann-La Roche Ltd. is a Swiss global health-care company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Roche is looking for first-in-class or best-in-class opportunities that address diseases of unmet medical need and have the potential to revolutionize the standard of care. Roche focuses on their main disease therapy areas – oncology and Immuno-oncology, ophthalmology, infectious diseases and neurosciences–as well as looking at opportunities in promising technologies and early-stage collaborations. Beyond the asset, Roche always look for the right partnership and cultural fit. Roche also seeks collaboration in diagnostics, specifically biomarkers.
Shafique Virani
Global Head Partnering (Neuro)Safeguard Scientifics
Gary Kurtzman
Managing DirectorSand Hill Angels
Stephen Pollitt
Board Member Membership ChairScience Futures
Nola Masterson
Managing DirectorSeroba Kernel Life Sciences
Seroba Kernel is a venture capital firm based in Dublin, Ireland, with representatives in the United Kingdom. The firm has approximately €100M AUM and focuses solely on the life sciences. The firm has 2 funds and plans to raise a third fund in the near future. The firm typically allocates between €5-7M of equity over the life of the investment. The firm primarily invests in companies that are based in Ireland and Europe. Exceptional opportunities in North America will also be considered. The firm is actively seeking new investment opportunities.
Daniel O'Mahony
PartnerShire
Shire is an Irish-headquartered global specialty biopharmaceutical company. Originating in the United Kingdom with a large operational base in the United States, its brands and products include Vyvanse, Adderall XR, Intuniv, Lialda, Pentasa, Fosrenol, Replagal, Elaprase, VPRIV, Firazyr and Dermagraft.
Shire is currently interested in several therapeutic areas for business development opportunities. The company is most interested in the following products: rare disease therapeutics, pre-clinical to on the market; neuroscience therapeutics, on the market; gastrointestinal, on the market; ophthalmology, post proof-of-concept; and hematology; post proof-of-concept.
Jane Daun-Tremblay
Sofia Angel Fund
Sofia Angel Group is a group of angel investors based in Minneapolis, Minnesota. The group solely focuses on investing in women-led businesses where women are the founders, or women are on the senior management team. Sofia Angel Group does not have a specific timeframe to make an investment, however would make an allocation by the end of 2013 if a compelling opportunity is identified. The group typically invests around $100,000 per company, however has the ability to invest up to $3 million through co-investments from the group’s members.
Barbara Nelsen
Sound Affects
Mona Jhaveri
Executive DirectorSTRATEC Biomedical AG
For more than 35 years STRATEC Biomedical AG is a business partner for the development and manufacture of fully automated analyzer systems. It's headquarter is located in Birkenfeld, Germany and it has nearly 500 employees in 5 locations worldwide. The public owned company has cooperations with 15 of the 20 IVD companies worldwide and has boosted its annual sales from USD 10.4 million in 1998 (IPO) to USD 122.4 million in 2014. STRATEC has strived to achieve market-leading expertise and to build a technology pool that is unique to its industry. The company invests in a variety of fields within the diagnostic and life science sector including medical devices.
Dr Claus Vielsack
Member Board of Management Product DevelopmentSymbient Product Development
Rapid Development of Injection Molded Medical Devices
From Concept Through Transfer-to-Manufacturing
Symbient specializes in engineering research and development, prototyping and design-for-manufacturing of innovative medical devices that use injection molded components. Our highly experienced team consists of mechanical and biomedical engineers, industrial designers, machinists and molding technicians. They leverage our in-house rapid prototyping, and prototype tooling fabrication and injection molding to create proven, manufacturable designs with unmatched speed, efficiency and precision. These designs make up our deep portfolio of over 300 successful devices that have collectively generated hundreds of millions of dollars. They include FDA Class I, II and III devices, developed under our ISO 13485 certified quality management system.
Our Services Include:
- Concept Development
- Development Engineering
- Design-for-Manufacturing
- Industrial Design
- Project Rescue
- Design Control per IOS 13485
- Finite Element Analysis (FEA)
- Design Verification Testing
- Test Method Development
- Transfer to Manufacturing
Our In-House Capabilities and Expertise Include:
- Stereolithography (SLA) Prototyping
- CNC Machining / Fabrication
- Prototype Mold Fabrication
- Prototype Injection Molding of Devices for Testing, Trials and Studies
- Liquid Injection Molded (LIM) Silicone Prototype Molding
- Product Reliability Testing
- Plastics Assembly Expertise: Ultrasonic and Laser Welding, Heat Sealing, Pressure Sensitive Adhesives, Swaging, Snap Fits, Press Fits, Interlocks.
- Speed: Prototype Molds in as little as 1 week and Modifications in as little as 1 Day
- Material Selection Expertise, Research and Testing to Ensure All Product Requirements Are Met.
Our Portfolio Includes:
- Diagnostics / Molecular Diagnostics
- Sample collection / preparation
- Life Sciences / Microfluidics
- OTC Consumer products
- Respiratory
- Surgical devices and clinical tools
- Drug Delivery